VITAL

Vital Chemtech Share Price

₹58.80 +0.5 (0.86%)

20 Jul, 2025 03:53

SIP TrendupStart SIP in VITAL

Start SIP

Performance

  • Low
  • ₹59
  • High
  • ₹59
  • 52 Week Low
  • ₹48
  • 52 Week High
  • ₹105
  • Open Price₹59
  • Previous Close₹58
  • Volume1,200

Investment Returns

  • Over 1 Month -13.47%
  • Over 3 Month -19.45%
  • Over 6 Month -20.22%
  • Over 1 Year -41.43%
SIP Lightning

Smart Investing Starts Here Start SIP with Vital Chemtech for Steady Growth!

Invest Now

Vital Chemtech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 141
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.84
  • EPS
  • 1.69
  • Dividend Yield
  • 0.9
  • MACD Signal
  • -1.63
  • RSI
  • 37.5
  • MFI
  • 27.08

Vital Chemtech Financials

Vital Chemtech Technicals

EMA & SMA

Current Price
₹58.80
+ 0.5 (0.86%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹61.93
  • 50 Day
  • ₹64.41
  • 100 Day
  • ₹66.61
  • 200 Day
  • ₹70.49

Resistance and Support

58.8 Pivot Speed
  • R3 58.80
  • R2 58.80
  • R1 58.80
  • S1 58.80
  • S2 58.80
  • S3 58.80

What's your outlook on Vital Chemtech?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vital Chemtech has an operating revenue of Rs. 281.95 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 44%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 40 indicates it belongs to a strong industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vital Chemtech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-30 Audited Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Re. 0.50 per equity share.
2024-05-29 Audited Results & Dividend
2023-05-22 Audited Results & Dividend
2023-03-30 Others To consider acquisition of substantial stake in Vital Alkoxides Private Limited (CIN: U24239GJ2021PTC126430 ) and thereby making it a subsidiary Company Final Dividend of Re. 0.50 per equity share.
Date Purpose Remarks
2024-09-13 FINAL Re.0.00 Final Dividend of Re. 0.50 per equity share.
2023-09-15 FINAL Recommended Final Dividend of 0.5 per equity share. Final Dividend of Re. 0.50 per equity share.
View More

Vital Chemtech F&O

Vital Chemtech Shareholding Pattern

73.43%
1.78%
20.82%
3.97%

About Vital Chemtech

  • NSE Symbol
  • VITAL
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Vipul Jatashanker Bhatt
  • ISIN
  • INE0L4K01016

Similar Stocks to Vital Chemtech

Vital Chemtech FAQs

Vital Chemtech share price is ₹58 As on 20 July, 2025 | 03:39

The Market Cap of Vital Chemtech is ₹140.8 Cr As on 20 July, 2025 | 03:39

The P/E ratio of Vital Chemtech is 34.7 As on 20 July, 2025 | 03:39

The PB ratio of Vital Chemtech is 1.5 As on 20 July, 2025 | 03:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23